2 hrs ago | Puget Sound Business Journal
Dendreon says FDA will disclose Provengea s fate by May 1
Puget Sound Business Journal Dendreon Corp. said the U.S. Food and Drug Administration said it will make a regulatory decision on the biotech's Provenge prostate cancer drug by May 1, 2010.
7 hrs ago | Earth Times
Police seize illicit medicines from web merchants - Summary
Wiesbaden, Germany/Washington - Police in 24 nations raided illegal internet pharmacies this week, intercepted parcels at mail depots and seized stocks of illicit medicines, German police and US officials said Thursday.
11 hrs ago | Fort Frances Times
U.S. stops Canadian canola meal shipments at border because of salmonella
The United States has stopped canola meal shipments from five Canadian plants at the border over concerns about potentially dangerous salmonella bacteria.
16 hrs ago | The Sligo Champion
Stem-cell transplants offer hope to patients losing sight
People suffering from a form of incurable blindness could soon become the first patients in the world to benefit from a new and controversial transplant operation using stem cells derived from spare human embryos left over from IVF treatment.
20 hrs ago | Drugs.com
Genentech, Biogen Get FDA Request on Rituxan
From Associated Press NEW YORK--Genentech Inc. and partner Biogen Idec Inc. said Wednesday the Food and Drug Administration is withholding a decision to expand approval of Rituxan as a leukemia treatment, pending further discussion.
FDA: Anticlotting drugs, PPIs may adversely affect each other
ROCKVILLE,A Md. Patients taking an anticlotting drug should avoid the use of a drug for gastroesophageal reflux disease, the Food and Drug Administration warned Wednesday.
FDA Issues 22 Internet Warning Letters
The U.S. Food and Drug Administration says it has issued warnings to 22 operators of Web sites about the illegal sale of unapproved or misbranded drugs.
AstraZeneca seeks Brilinta approval in US
AstraZeneca PLC said Thursday it has applied to U.S. regulators to market its blood clot preventer Brilinta, a potential new big seller for the company.
Senate panel passes food safety reform bill
A Senate committee passed legislation on Wednesday that would increase government oversight of the U.S. food supply, which has been battered by a series of high-profile recalls that have soured consumer confidence in the food safety system.
Judges: Seattle biotech can pursue $23M claim
Seattle biotechnology firm Cell Therapeutics Inc. can pursue claims for nearly $23 million against a former consultant, a federal appeals court ruled Wednesday.
FDA Bows To Pressure From Fans Of Raw Oysters
The FDA's proposal to treat raw oysters had sparked an outcry among diners. Legend has it that raw oysters are good for love - but they're also worth fighting over, as the Food and Drug Administration has learned.
Genentech submits sBLAs to the FDA for Avastin
Genentech, Inc., a wholly-owned member of the Roche Group , today announced that the company submitted two supplemental Biologics License Applications to the U.S. Food and Drug Administration for AvastinA for the treatment of women who have not received chemotherapy for advanced HER2-negative breast cancer .
Medtronic Gets FDA Warning on Heart Implant Unit
FILE - In this Aug. 16, 2005, the "Rising Man" symbol stands in front of the Fridley, Minn., based... FILE - In this Aug.
Par Pharma gets FDA approval for generic Ultram ER
Par Pharmaceutical Co. said Monday it received marketing approval for a generic version of Johnson & Johnson 's extended-release chronic pain drug Ultram ER, and has started shipping the drug.
Majority of Wyoming voters support new government oversight of food, Pew-commissioned poll finds
An overwhelming majority of Wyoming voters -- 88 percent -- support food safety legislation that would give the Food and Drug Administration new authority to ensure the food Americans eat does not make them sick, according to a new poll commissioned by the Pew Health Group and conducted by Hart Research and Public Opinion Strategies.
FDA approves fifth H1N1 vaccine
ROCKVILLE,A Md. The Food and Drug Administration on Monday announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus, this one manufactured by ID Biomedical of Quebec, Canada, which is owned by GlaxoSmithKline.
Qutenza approved for post-shingles nerve pain
The Qutenza skin patch has been approved by the U.S. Food and Drug Administration to treat pain due to postherpetic neuralgia , the nerve pain that may follow shingles, drug maker NeurogesX said in a news release.
FDA warns that heartburn drug Prilosec can block benefits of blood thinner Plavix
Federal health officials said Tuesday a popular heartburn medication can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.
Novartis: Lower vaccine dose sufficient
Pharmaceutical maker Novartis AG said Tuesday a U.S. clinical study suggests that half a dose of its swine flu vaccine may be sufficient to protect people from the virus and could allow many more to be immunized with current supplies.
Lysteda Approved for Heavy Menstrual Bleeding
Tranexamic acid has been approved by the U.S. Food and Drug Administration as the first non-hormonal drug to treat heavy menstrual bleeding, a medical condition called menorrhagia.
Also on Topix